Congress trades

Catalent, Inc. (CTLT)

NYSE · Healthcare · 36 congress trades · last filed 2 years agono longer trading under this ticker

20
Congress disclosures shown
20d
Median delay on the congress disclosures
of the 45 day limit
8/12
Purchases and sales in the disclosures shown

About Catalent, Inc.

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chief executive
Alessandro Maselli
Employees
17,000
Listed since
-
Market value
$11.5B
Price to earnings
-
Earnings per share
-$5.76
Dividend yield
-

www.catalent.com

Earnings

6 reported quarters
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q1 FY2025reported Nov 5, 2024-$0.13-$0.03$1.0B$1.1BEPS missRevenue miss
Aug 29, 2024$0.65$0.47$1.3B$1.2BEPS beatRevenue beat
Q3 FY2024reported May 8, 2024-$0.06$0.22$1.1B$1.1BEPS missRevenue miss
Q2 FY2024reported Feb 9, 2024-$0.24-$0.02$1.0B$1.1BEPS missRevenue miss
Nov 15, 2023-$0.10-$0.13$982.0M$940.2MEPS beatRevenue beat
Aug 29, 2023$0.09$0.10$1.1B$1.1BEPS missRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Know the moment the next CTLT filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in CTLT

20 disclosures of 36 on record · median 20d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockSale$1,001 - $15,000+18.5%S&P +14.8% · vs S&P 500 +3.6%May 29, 2024Jun 5, 20247d
Ro KhannaStockPurchase$1,001 - $15,000+13.5%S&P +18.9% · vs S&P 500 -5.4%Apr 26, 2024May 6, 202410d
Ro KhannaStockSale$1,001 - $15,000+70.8%S&P +44.4% · vs S&P 500 +26.4%May 19, 2023Jun 12, 202324d
Ro KhannaStockSale$1,001 - $15,000+66.5%S&P +46.0% · vs S&P 500 +20.5%May 23, 2023Jun 12, 202320d
Ro KhannaStockPurchase$1,001 - $15,000+49.9%S&P +48.9% · vs S&P 500 +1.0%Apr 25, 2023May 8, 202313d
Daniel S. GoldmanStockPurchase$1,001 - $15,000-6.4%S&P +51.8% · vs S&P 500 -58.2%Mar 7, 2023Apr 17, 202341d
Ro KhannaStockSale$1,001 - $15,000-1.2%S&P +52.8% · vs S&P 500 -54.0%Mar 24, 2023Apr 7, 202314d
Ro KhannaStockPurchase$1,001 - $15,000-9.8%S&P +46.5% · vs S&P 500 -56.2%Feb 14, 2023Mar 3, 202317d
Susie LeeJointStockSale$1,001 - $15,000+26.6%S&P +48.3% · vs S&P 500 -21.7%Nov 30, 2022Dec 29, 202229d
Ro KhannaStockPurchase$1,001 - $15,000+50.3%S&P +63.0% · vs S&P 500 -12.7%Nov 3, 2022Dec 6, 202233d
Ro KhannaStockSale$1,001 - $15,000-35.6%S&P +52.3% · vs S&P 500 -87.8%May 23, 2022Jun 10, 202218d
Ro KhannaStockPurchase$1,001 - $15,000-36.9%S&P +46.0% · vs S&P 500 -82.9%May 5, 2022Jun 10, 202236d
Ro KhannaStockPurchase$1,001 - $15,000-37.8%S&P +37.9% · vs S&P 500 -75.7%Jan 21, 2022Feb 8, 202218d
Thomas R. SuozziFiled lateStockSale$1,001 - $15,000-36.9%S&P +44.3% · vs S&P 500 -81.2%Jun 3, 2021Sep 23, 2021112d
Thomas R. SuozziFiled lateStockPurchase$1,001 - $15,000-39.5%S&P +63.1% · vs S&P 500 -102.6%Dec 18, 2020Sep 23, 2021279d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-25.5%S&P +81.9% · vs S&P 500 -107.4%Sep 29, 2020Oct 14, 202015d
Josh GottheimerJointStockSale$1,001 - $15,000-21.4%S&P +86.1% · vs S&P 500 -107.5%Sep 24, 2020Oct 13, 202019d
Josh GottheimerJointStockSale$1,001 - $15,000-27.7%S&P +79.2% · vs S&P 500 -106.8%Aug 12, 2020Sep 20, 202039d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-30.3%S&P +78.9% · vs S&P 500 -109.1%Aug 17, 2020Sep 14, 202028d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-29.0%S&P +69.0% · vs S&P 500 -98.0%Sep 2, 2020Sep 14, 202012d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Questions

Which members of Congress have traded CTLT?

Ro Khanna, Daniel S. Goldman, Susie Lee, Thomas R. Suozzi, Gilbert Ray Cisneros, Jr., Josh Gottheimer disclosed CTLT transactions in the filings shown here.

How quickly are CTLT trades disclosed?

Congressional disclosures took a median of 20 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track